UnitedHealthcare Delays Major RPM Coverage Changes

UnitedHealthcare has paused the rollout of its widely debated RPM coverage restrictions originally set to take effect January 1, 2026. After pushback from providers, medical societies, and digital health advocates, UHC confirmed the policy will be implemented later in 2026, with timing and details still to be finalized.

Here’s what providers and patients should know right now:

👉 Current coverage remains broad With the delay in place, clinicians can continue billing under existing RPM coverage for a wide range of chronic conditions (including hypertension, Type 2 diabetes, and COPD) until UHC announces a new implementation timeline.

👉 What the proposed policy would do Under the policy announced in late 2025, RPM would be considered “reasonable and necessary” only for chronic heart failure and hypertensive disorders of pregnancy.

RPM would be deemed “not medically necessary” for other common use cases such as diabetes management, general hypertension, COPD, sleep apnea, and behavioral health.

UHC has cited “insufficient evidence” for broader RPM benefit, a stance challenged by clinicians and researchers pointing to growing real-world evidence across chronic conditions.

👉 What Providers should do now - Review RPM patient panels for potential future impact - Monitor payer updates and reimbursement guidance - Continue documenting outcomes that demonstrate RPM’s clinical value

👉 What this means for patients For patients enrolled in RPM programs, nothing changes immediately. However, care teams should remain proactive and discuss contingency plans should coverage policies shift later in 2026.

We’ll continue tracking updates from UHC and other major payers as we progress through the year!